Table 2 of Bessho, Mol Vis 2011; 17:977-982.

Table 2. Clinical details of polypoidal choroidal vasculopathy (PCV) patients stratified by the genotype of rs10490924 in the age-related maculopathy susceptibility 2 (ARMS2) gene.

n=119 G/G G/T T/T P
Gender (female/male) 3/21 8/38 12/37 0.43†
Age (mean±SD, years) 73±9 73±7 72±8 0.88*
GLD (mean±SD, μm) 3475±1615 3051±1550 4342±1737 0.00073*
Number of PDT sessions/year (mean±SD) 1.5±0.7 1.5±0.5 1.6±0.7 0.75*
Baseline BCVA log MAR (mean±SD) 0.79±0.41 0.62±0.32 0.65±0.34 0.27*
12Mo BCVA log MAR (mean±SD) 0.59±0.50 0.47±0.44 0.71±0.41 0.014*
12Mo-Baseline BCVA log MAR (mean±SD) −0.20±0.39 −0.15±0.45 0.06±0.41 0.012*

Abbreviations: GLD represents greatest linear dimension, PDT represents photodynamic therapy, BCVA represents best-corrected visual acuity, Mo represents month. † χ2 test, * Kruskal–Wallis test.

Bessho, Mol Vis 2011; 17:977-982. http://www.molvis.org/molvis/v17/a108

©2011 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535